Giuseppe Marrone
Overview
Explore the profile of Giuseppe Marrone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lai Q, Lenci I, Giannelli V, Marrone G
Liver Int
. 2023 Aug;
43(10):2328-2329.
PMID: 37592871
No abstract available.
12.
Miele L, Dajko M, Savino M, Capocchiano N, Calvez V, Liguori A, et al.
Intern Emerg Med
. 2023 Jul;
18(5):1415-1427.
PMID: 37491564
Increased values of the FIB-4 index appear to be associated with poor clinical outcomes in COVID-19 patients. This study aimed to develop and validate predictive mortality models, using data upon...
13.
Marrone G, Serra A, Miele L, Biolato M, Liguori A, Grieco A, et al.
World J Gastroenterol
. 2023 Jun;
29(19):2905-2915.
PMID: 37274800
Liver cirrhosis is commonly associated with nutritional alterations, reported in 20% of patients with compensated disease and over 60% of patients with decompensated cirrhosis. Nutritional disturbances are associated with a...
14.
Biolato M, DErrico A, Rognoni F, Marrone G, Laurenti L, Cina A, et al.
Gastroenterol Rep (Oxf)
. 2023 May;
11:goad025.
PMID: 37251505
No abstract available.
15.
Biolato M, Vitale F, Marrone G, Miele L, Grieco A
Medicine (Baltimore)
. 2022 Nov;
101(44):e31429.
PMID: 36343065
Rationale: Lusutrombopag is a thrombopoietin receptor agonist which reduces the need for platelet transfusions before planned invasive procedures. A post hoc analysis of data from the registration trials observed that...
16.
Biolato M, Vitale F, Marrone G, Miele L, Grieco A
Gastroenterol Rep (Oxf)
. 2022 Nov;
10:goac059.
PMID: 36340807
No abstract available.
17.
Lai Q, De Matthaeis N, Finotti M, Galati G, Marrone G, Melandro F, et al.
Eur J Clin Invest
. 2022 Sep;
53(1):e13870.
PMID: 36075611
Aim: To evaluate the impact of antiplatelet therapy (APT)on the incidence of hepatocellular carcinoma (HCC) and mortality following its treatment. Methods: A systematic literature search was performed using PubMed and...
18.
Coppola A, Bianco G, Lai Q, Marrone G, Caimano M, Agnes S, et al.
BMJ Open
. 2022 Aug;
12(8):e063081.
PMID: 35914905
Introduction: Viability assessment of the graft is essential to lower the risk of liver transplantation (LT) failure and need for emergency retransplantation, however, this still relies mainly on surgeon's experience....
19.
Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A
World J Hepatol
. 2022 Jun;
14(4):682-695.
PMID: 35646264
In recent years, the traditional concept that cirrhosis-related coagulopathy is an acquired bleeding disorder has evolved. Currently, it is known that in cirrhotic patients, the hemostatic system is rebalanced, which...
20.
Biolato M, Galasso T, Marrone G, Miele L, Grieco A
Cancers (Basel)
. 2021 Dec;
13(24).
PMID: 34944957
In Europe and the United States, approximately 1100 and 1800 liver transplantations, respectively, are performed every year for hepatocellular carcinoma (HCC), compared with an annual incidence of 65,000 and 39,000...